Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program

John B Carlin, Kristine K Macartney, Katherine J Lee, Helen E Quinn, James Peter Buttery, Ruth Lopert, Julie E Bines, Peter McIntyre

Research output: Contribution to journalArticleResearchpeer-review

114 Citations (Scopus)

Abstract

Estimates of the risk of intussusception (IS) associated with currently licensed rotavirus vaccines (RV1 [Rotarix; GSK] and RV5 [RotaTeq; Merck] diverge. Contemporaneous introduction of both vaccines in Australia enabled a population-based assessment of risk.
Original languageEnglish
Pages (from-to)1427 - 1434
Number of pages8
JournalClinical Infectious Diseases
Volume57
Issue number10
DOIs
Publication statusPublished - 2013

Cite this

Carlin, John B ; Macartney, Kristine K ; Lee, Katherine J ; Quinn, Helen E ; Buttery, James Peter ; Lopert, Ruth ; Bines, Julie E ; McIntyre, Peter. / Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. In: Clinical Infectious Diseases. 2013 ; Vol. 57, No. 10. pp. 1427 - 1434.
@article{233282b5717f4485a70e37b1788298cd,
title = "Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program",
abstract = "Estimates of the risk of intussusception (IS) associated with currently licensed rotavirus vaccines (RV1 [Rotarix; GSK] and RV5 [RotaTeq; Merck] diverge. Contemporaneous introduction of both vaccines in Australia enabled a population-based assessment of risk.",
author = "Carlin, {John B} and Macartney, {Kristine K} and Lee, {Katherine J} and Quinn, {Helen E} and Buttery, {James Peter} and Ruth Lopert and Bines, {Julie E} and Peter McIntyre",
year = "2013",
doi = "10.1093/cid/cit520",
language = "English",
volume = "57",
pages = "1427 -- 1434",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "10",

}

Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. / Carlin, John B; Macartney, Kristine K; Lee, Katherine J; Quinn, Helen E; Buttery, James Peter; Lopert, Ruth; Bines, Julie E; McIntyre, Peter.

In: Clinical Infectious Diseases, Vol. 57, No. 10, 2013, p. 1427 - 1434.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program

AU - Carlin, John B

AU - Macartney, Kristine K

AU - Lee, Katherine J

AU - Quinn, Helen E

AU - Buttery, James Peter

AU - Lopert, Ruth

AU - Bines, Julie E

AU - McIntyre, Peter

PY - 2013

Y1 - 2013

N2 - Estimates of the risk of intussusception (IS) associated with currently licensed rotavirus vaccines (RV1 [Rotarix; GSK] and RV5 [RotaTeq; Merck] diverge. Contemporaneous introduction of both vaccines in Australia enabled a population-based assessment of risk.

AB - Estimates of the risk of intussusception (IS) associated with currently licensed rotavirus vaccines (RV1 [Rotarix; GSK] and RV5 [RotaTeq; Merck] diverge. Contemporaneous introduction of both vaccines in Australia enabled a population-based assessment of risk.

UR - http://cid.oxfordjournals.org/content/57/10/1427.full.pdf+html

U2 - 10.1093/cid/cit520

DO - 10.1093/cid/cit520

M3 - Article

VL - 57

SP - 1427

EP - 1434

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 10

ER -